[Cellular exudation in patients with primary chronic polyarthritis in Rebuck's skin window experiments].
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000494:pharmacology / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000473:pathology*; D002464:Cell Migration Inhibition; D002633:Chemotaxis / Q000187:drug effects; D005122:Exudates and Transudates / Q000166:cytology*; D005938:Glucocorticoids / Q000494:pharmacology; D006801:Humans; D008264:Macrophages / Q000187:drug effects; D008775:Methylprednisolone / Q000494:pharmacology / Q000627:therapeutic use; D009000:Monocytes / Q000187:drug effects; D009504:Neutrophils / Q000187:drug effects; D011239:Prednisolone; D012884:Skin Window Technique; D013194:Staining and Labeling
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D011239:Prednisolone; D008775:Methylprednisolone
Untersuchungen zur zellulären Exsudation bei Kranken mit primär chronischer Polyarthritis in Hautfensterversuchen nach Rebuck